Literature DB >> 35621287

Case - Orlistat-induced calcium oxalate crystalluria.

Greta Handing1, Ujval Ishu Pathak2, Adithya Balasubramanian3, Alexander Liu4, Wesley A Mayer4.   

Abstract

Entities:  

Year:  2022        PMID： 35621287      PMCID： PMC9565061          DOI： 10.5489/cuaj.7900

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   2.052


× No keyword cloud information.
  15 in total

Review 1.  Orlistat and calcium oxalate crystalluria: an association that needs consideration.

Authors:  Mohamed H Ahmed
Journal:  Ren Fail       Date:  2010       Impact factor: 2.606

2.  Orlistat, an under-recognised cause of progressive renal impairment.

Authors:  Andrew K Coutinho; Gerald R Glancey
Journal:  Nephrol Dial Transplant       Date:  2013-09-18       Impact factor: 5.992

3.  Patterns and predictors of medication discrepancies in primary care.

Authors:  Daniel J Coletti; Hara Stephanou; Nissa Mazzola; Joseph Conigliaro; JoAnne Gottridge; John M Kane
Journal:  J Eval Clin Pract       Date:  2015-05-29       Impact factor: 2.431

4.  Acute oxalate nephropathy secondary to orlistat-induced enteric hyperoxaluria.

Authors:  Tony K Kwan; Steve J Chadban; Paul R McKenzie; John R Saunders
Journal:  Nephrology (Carlton)       Date:  2013-03       Impact factor: 2.506

Review 5.  Orlistat: current status in clinical therapeutics.

Authors:  Katie S McClendon; Daniel M Riche; Gabriel Ikponmosa Uwaifo
Journal:  Expert Opin Drug Saf       Date:  2009-11       Impact factor: 4.250

Review 6.  Primary and secondary hyperoxaluria: Understanding the enigma.

Authors:  Bhavna Bhasin; Hatice Melda Ürekli; Mohamed G Atta
Journal:  World J Nephrol       Date:  2015-05-06

7.  Orlistat-induced oxalate nephropathy: an under-recognised cause of chronic kidney disease.

Authors:  Laurence Richard Solomon; Andrew Christopher Nixon; Leanne Ogden; Beena Nair
Journal:  BMJ Case Rep       Date:  2017-11-12

8.  Obesity, weight gain, and the risk of kidney stones.

Authors:  Eric N Taylor; Meir J Stampfer; Gary C Curhan
Journal:  JAMA       Date:  2005-01-26       Impact factor: 56.272

9.  Acute oxalate nephropathy associated with orlistat.

Authors:  Youshay Humayun; Kenneth C Ball; Jack R Lewin; Anna A Lerant; Tibor Fülöp
Journal:  J Nephropathol       Date:  2016-03-29

10.  Acute oxalate nephropathy associated with orlistat: a case report with a review of the literature.

Authors:  Dhara Chaudhari; Conchitina Crisostomo; Charles Ganote; George Youngberg
Journal:  Case Rep Nephrol       Date:  2013-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.